Group items tagged

Peptide therapeutics continue to expand its applications as research continues to expand the potential range of peptide-based pharmaceuticals by engineering enhanced pharmaceutical properties to focus on treatment targets. Moreover, continuous research and development is in progress to enhance the central nervous system, to improve the oral bioavailability of peptide therapeutics, and to extend the half-life period of peptide therapeutics. Growth of the peptide therapeutics market is mainly driven by the increasing adoption of peptide therapeutics.

Glycosylated peptide (or glycopeptides) is another class of medications utilized against a few illness because of its highlights, like low poisonousness, target explicitness, high action, and insignificant vague or medication drug connections. It is a promising procedure for changing the physicochemical properties of peptide drugs and for the passage of peptides into natural films.

Peptide cancer vaccines are a major source of vaccination against a wide range of cancer diseases such as ovarian cancer, cervical cancer, leukemia, and pancreatic cancer.

Human growth hormone or somatotropin in its normal human version, is a protein peptide hormone which stimulates cell reproduction, cell growth, and body mass and strength.

Protein hydrolysate components are peptides that are generated from proteins. Protein hydrolysates have a higher protein content and are absorbed faster than other proteins. Milk protein hydrolysate and beef protein hydrolysate are two types of protein hydrolysate components. The antigenic characteristics of these protein hydrolysate components are rather modest. Protein hydrolysates components improve digestibility and minimise protein allergy, particularly in newborns.